Portfolio Holdings Detail for ISIN IE00BFF5RZ82
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / Fund iShares Edge MSCI USA Momentum Factor UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker IUMD(USD) LSE
ETF Ticker IUMD.L(GBP) LSE

Holdings detail for RPRX

Stock Name	Royalty Pharma Plc
Ticker	RPRX(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	GB00BMVP7Y09
LEI	549300FGFN7VOK8BZR03

Show aggregate RPRX holdings

News associated with RPRX

Royalty Pharma Expects At Least Mid-teens Average Annual Total Shareholder Return Over 2025-2030.: (RTTNews) - Royalty Pharma plc (RPRX) Thursday said it will host an Investor Day today, where senior executives will provide updates on the company's strategies aimed at driving shareholder value creation. - 2025-09-11 08:35:29
Maryland State Retirement & Pension System Trims Stock Position in Royalty Pharma PLC (NASDAQ:RPRX): Maryland State Retirement & Pension System lessened its position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 18.4% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 18,291 shares of the biopharmaceutical company’s stock after selling 4,133 shares during the quarter. […] - 2025-08-15 05:22:58
PNC Financial Services Group Inc. Acquires 859 Shares of Royalty Pharma PLC (NASDAQ:RPRX): PNC Financial Services Group Inc. boosted its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 7.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,665 shares of the biopharmaceutical company’s stock after purchasing an additional […] - 2025-08-15 04:48:59
Blair William & Co. IL Invests $212,000 in Royalty Pharma PLC (NASDAQ:RPRX): Blair William & Co. IL bought a new position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 6,801 shares of the biopharmaceutical company’s stock, valued at approximately $212,000. A number of other hedge […] - 2025-08-13 07:56:48
Deutsche Bank AG Sells 1,775,038 Shares of Royalty Pharma PLC (NASDAQ:RPRX): Deutsche Bank AG lessened its holdings in Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 55.6% during the 1st quarter, Holdings Channel.com reports. The firm owned 1,414,926 shares of the biopharmaceutical company’s stock after selling 1,775,038 shares during the period. Deutsche Bank AG’s holdings in Royalty Pharma were worth $44,047,000 as of its most recent […] - 2025-08-13 05:54:50
Charles Schwab Investment Management Inc. Has $97.20 Million Stock Holdings in Royalty Pharma PLC (NASDAQ:RPRX): Charles Schwab Investment Management Inc. cut its holdings in Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 0.3% in the 1st quarter, Holdings Channel.com reports. The firm owned 3,122,531 shares of the biopharmaceutical company’s stock after selling 9,097 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Royalty Pharma were worth $97,204,000 as […] - 2025-08-13 05:10:46
Royalty Pharma (NASDAQ:RPRX) Raised to Buy at Wall Street Zen: Royalty Pharma (NASDAQ:RPRX – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday. A number of other equities research analysts also recently weighed in on the company. Morgan Stanley boosted their target price on Royalty Pharma from $51.00 […] - 2025-08-11 03:50:55
Allianz Asset Management GmbH Has $6.03 Million Stock Holdings in Royalty Pharma PLC (NASDAQ:RPRX): Allianz Asset Management GmbH reduced its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 64.8% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 193,591 shares of the biopharmaceutical company’s stock after selling 356,968 shares during the period. Allianz […] - 2025-07-28 07:00:47
Edgestream Partners L.P. Invests $659,000 in Royalty Pharma PLC (NASDAQ:RPRX): Edgestream Partners L.P. acquired a new position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 21,158 shares of the biopharmaceutical company’s stock, valued at approximately $659,000. Other hedge funds and other institutional investors also […] - 2025-07-20 05:24:59
Cerity Partners LLC Boosts Stake in Royalty Pharma PLC (NASDAQ:RPRX): Cerity Partners LLC raised its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 786.3% during the 1st quarter, Holdings Channel reports. The fund owned 153,846 shares of the biopharmaceutical company’s stock after purchasing an additional 136,487 shares during the period. Cerity Partners LLC’s holdings in Royalty Pharma were worth $4,789,000 as […] - 2025-07-17 05:00:57
Xponance Inc. Acquires 1,437 Shares of Royalty Pharma PLC (NASDAQ:RPRX): Xponance Inc. raised its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 3.7% in the first quarter, HoldingsChannel.com reports. The firm owned 40,133 shares of the biopharmaceutical company’s stock after buying an additional 1,437 shares during the period. Xponance Inc.’s holdings in Royalty Pharma were worth $1,249,000 as of its most […] - 2025-07-16 05:48:56
M&T Bank Corp Buys 5,500 Shares of Royalty Pharma PLC (NASDAQ:RPRX): M&T Bank Corp raised its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 23.4% in the 1st quarter, Holdings Channel reports. The firm owned 28,967 shares of the biopharmaceutical company’s stock after acquiring an additional 5,500 shares during the period. M&T Bank Corp’s holdings in Royalty Pharma were worth $902,000 at […] - 2025-07-15 06:23:30
Teacher Retirement System of Texas Cuts Stock Position in Royalty Pharma PLC (NASDAQ:RPRX): Teacher Retirement System of Texas cut its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 10.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 103,364 shares of the biopharmaceutical company’s stock after selling 12,028 shares during the […] - 2025-07-09 05:33:01
Allspring Global Investments Holdings LLC Boosts Stake in Royalty Pharma PLC (NASDAQ:RPRX): Allspring Global Investments Holdings LLC boosted its position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 4.0% in the first quarter, Holdings Channel.com reports. The institutional investor owned 561,724 shares of the biopharmaceutical company’s stock after acquiring an additional 21,729 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Royalty […] - 2025-07-03 06:09:03
11,210 Shares in Royalty Pharma PLC (NASDAQ:RPRX) Acquired by Kentucky Retirement Systems Insurance Trust Fund: Kentucky Retirement Systems Insurance Trust Fund acquired a new stake in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) in the first quarter, HoldingsChannel reports. The firm acquired 11,210 shares of the biopharmaceutical company’s stock, valued at approximately $349,000. Other hedge funds also recently bought and sold shares of the company. Louisbourg Investments Inc. […] - 2025-06-26 05:42:57
After Hours Most Active for Jun 24, 2025 : SNAP, NVDA, CMCSA, PLTR, INTC, SPR, AUR, RPRX, KVUE, MPW, GM, WMT: The NASDAQ 100 After Hours Indicator is down -.81 to 22,189.71. The total After hours volume is currently 173,627,396 shares traded.The following are the most active stocks for the after hours session: Snap Inc. (SNAP) is unchanged at $8.32, with 14,501,942 shares traded. SNAP's - 2025-06-24 17:24:56
Manning & Napier Advisors LLC Sells 44,505 Shares of Royalty Pharma PLC (NASDAQ:RPRX): Manning & Napier Advisors LLC lessened its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 54.9% during the first quarter, HoldingsChannel.com reports. The firm owned 36,549 shares of the biopharmaceutical company’s stock after selling 44,505 shares during the quarter. Manning & Napier Advisors LLC’s holdings in Royalty Pharma were worth $1,138,000 […] - 2025-06-24 05:20:57
After Hours Most Active for Jun 11, 2025 : PLTR, NVDA, AMZN, AAPL, RPRX, MCHPP: The NASDAQ 100 After Hours Indicator is up 14.32 to 21,875.12. The total After hours volume is currently 131,070,110 shares traded.The following are the most active stocks for the after hours session: Palantir Technologies Inc. (PLTR) is +0.25 at $136.64, with 5,538,416 shares t - 2025-06-11 17:24:56
Rhumbline Advisers Has $14.01 Million Position in Royalty Pharma plc (NASDAQ:RPRX): Rhumbline Advisers lowered its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 0.9% during the first quarter, HoldingsChannel reports. The firm owned 449,964 shares of the biopharmaceutical company’s stock after selling 4,184 shares during the quarter. Rhumbline Advisers’ holdings in Royalty Pharma were worth $14,007,000 as of its most recent SEC […] - 2025-06-09 05:24:51
Lazard Asset Management LLC Reduces Holdings in Royalty Pharma plc (NASDAQ:RPRX): Lazard Asset Management LLC lowered its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 4.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 23,457 shares of the biopharmaceutical company’s stock after selling 1,130 shares during the quarter. Lazard Asset […] - 2025-05-22 05:46:49
Royalty Pharma plc (NASDAQ:RPRX) Receives Average Rating of “Buy” from Brokerages: Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) has received a consensus recommendation of “Buy” from the five research firms that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. […] - 2025-05-22 04:50:51
Captrust Financial Advisors Sells 14,499 Shares of Royalty Pharma plc (NASDAQ:RPRX): Captrust Financial Advisors reduced its position in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 49.4% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 14,829 shares of the biopharmaceutical company’s stock after selling 14,499 shares during the quarter. Captrust Financial Advisors’ holdings in Royalty Pharma were worth $378,000 as of […] - 2025-05-20 04:52:44
Analysts Predict 10% Gains Ahead For The Holdings of EUSA: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-19 07:59:43
Royalty Pharma (NASDAQ:RPRX) Raised to “Buy” at StockNews.com: Royalty Pharma (NASDAQ:RPRX – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Monday. Separately, Citigroup reiterated a “buy” rating on shares of Royalty Pharma in a research report on Friday, March 28th. One equities research analyst has rated […] - 2025-05-14 02:14:45
Stifel Financial Corp Lowers Stake in Royalty Pharma plc (NASDAQ:RPRX): Stifel Financial Corp reduced its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 11.4% in the fourth quarter, Holdings Channel reports. The firm owned 17,152 shares of the biopharmaceutical company’s stock after selling 2,200 shares during the period. Stifel Financial Corp’s holdings in Royalty Pharma were worth $438,000 at the end […] - 2025-05-13 04:50:58
Prudential Financial Inc. Has $488,000 Stake in Royalty Pharma plc (NASDAQ:RPRX): Prudential Financial Inc. lowered its holdings in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 4.9% during the fourth quarter, Holdings Channel.com reports. The firm owned 18,360 shares of the biopharmaceutical company’s stock after selling 955 shares during the period. Prudential Financial Inc.’s holdings in Royalty Pharma were worth $488,000 at the end of the […] - 2025-04-10 05:01:02
American Century Companies Inc. Boosts Holdings in Royalty Pharma plc (NASDAQ:RPRX): American Century Companies Inc. grew its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 5.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 67,160 shares of the biopharmaceutical company’s stock after buying an additional 3,671 shares […] - 2025-04-10 04:26:56
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by JPMorgan Chase & Co.: JPMorgan Chase & Co. lifted its stake in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 8.2% in the 4th quarter, Holdings Channel reports. The firm owned 1,395,242 shares of the biopharmaceutical company’s stock after purchasing an additional 105,824 shares during the quarter. JPMorgan Chase & Co.’s holdings in Royalty Pharma were worth $35,593,000 at […] - 2025-04-08 04:44:55
Schroder Investment Management Group Sells 354,483 Shares of Royalty Pharma plc (NASDAQ:RPRX): Schroder Investment Management Group lowered its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 64.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 196,359 shares of the biopharmaceutical company’s stock after selling 354,483 shares during the quarter. Schroder Investment Management […] - 2025-04-06 05:29:08
Analysts Set Royalty Pharma plc (NASDAQ:RPRX) PT at $41.60: Shares of Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) have earned a consensus rating of “Buy” from the six research firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating […] - 2025-03-31 02:14:52

iShares Edge MSCI USA Momentum Factor UCITS ETF USD (Dist) RPRX holdings

Date	Number of RPRX Shares Held	Base Market Value of RPRX Shares	Local Market Value of RPRX Shares	Change in RPRX Shares Held	Change in RPRX Base Value	Current Price per RPRX Share Held	Previous Price per RPRX Share Held
2025-12-03 (Wednesday)	22,411	USD 887,476	USD 887,476	0	USD 1,569	USD 39.6	USD 39.53
2025-12-02 (Tuesday)	22,411	USD 885,907	USD 885,907	0	USD -8,292	USD 39.53	USD 39.9
2025-12-01 (Monday)	22,411	USD 894,199	USD 894,199	-27	USD -3,770	USD 39.9	USD 40.02
2025-11-28 (Friday)	22,438	USD 897,969	USD 897,969	0	USD 4,039	USD 40.02	USD 39.84
2025-11-27 (Thursday)	22,438	USD 893,930	USD 893,930	0	USD 0	USD 39.84	USD 39.84
2025-11-26 (Wednesday)	22,438	USD 893,930	USD 893,930	0	USD 6,731	USD 39.84	USD 39.54
2025-11-25 (Tuesday)	22,438	USD 887,199	USD 887,199	0	USD -4,712	USD 39.54	USD 39.75
2025-11-24 (Monday)	22,438	USD 891,911	USD 891,911	1,873	USD 91,521	USD 39.75	USD 38.92
2025-11-21 (Friday)	20,565	USD 800,390	USD 800,390	0	USD 10,900	USD 38.92	USD 38.39
2025-11-20 (Thursday)	20,565	USD 789,490	USD 789,490	0	USD -5,347	USD 38.39	USD 38.65
2025-11-19 (Wednesday)	20,565	USD 794,837	USD 794,837	0	USD -16,658	USD 38.65	USD 39.46
2025-11-18 (Tuesday)	20,565	USD 811,495	USD 811,495	-276	USD -4,639	USD 39.46	USD 39.16
2025-11-17 (Monday)	20,841	USD 816,134	USD 816,134	0	USD 0	USD 39.16	USD 39.16

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of RPRX by Blackrock for IE00BFF5RZ82

Show aggregate share trades of RPRX

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-01 SELL -27 40.500 39.600 39.690 USD -1,072 36.54 Loss of -85 on sale
2025-11-24 BUY 1,873 39.830 37.310 37.562 USD 70,354 36.35
2025-11-18 SELL -276 39.460* 36.23 Profit of 10,001 on sale
2025-11-10 SELL -538 39.399 38.510 38.599 USD -20,766 36.00 Loss of -1,396 on sale
2025-11-06 SELL -269 41.240 40.020 40.142 USD -10,798 35.91 Loss of -1,140 on sale
2025-11-03 BUY 540 37.715 37.130 37.189 USD 20,082 35.80
2025-10-24 SELL -269 37.260 37.395 37.382 USD -10,056 35.69 Loss of -456 on sale
2025-10-23 BUY 538 36.850 37.160 37.129 USD 19,975 35.67
2025-10-22 BUY 269 36.840 37.690 37.605 USD 10,116 35.65
2025-10-21 SELL -269 37.480 37.520 37.516 USD -10,092 35.62 Loss of -510 on sale
2025-10-20 BUY 269 36.630 36.920 36.891 USD 9,924 35.60
2025-10-14 SELL -269 36.000 36.130 36.117 USD -9,715 35.55 Loss of -152 on sale
2025-10-13 BUY 807 35.440 35.975 35.921 USD 28,989 35.55
2025-10-01 BUY 804 36.320 36.455 36.442 USD 29,299 35.50
2025-09-30 BUY 268 35.280 35.540 35.514 USD 9,518 35.50
2025-09-11 SELL -267 36.700 36.940 36.916 USD -9,857 35.50 Loss of -379 on sale
2025-07-31 BUY 223 36.800 37.550 37.475 USD 8,357 35.38
2025-07-30 SELL -223 37.120 37.500 37.462 USD -8,354 35.34 Loss of -473 on sale
2025-07-25 SELL -223 36.670 36.710 36.706 USD -8,185 35.20 Loss of -337 on sale
2025-07-24 BUY 446 36.590 36.660 36.653 USD 16,347 35.16
2025-07-14 SELL -223 36.240 36.330 36.321 USD -8,100 35.02 Loss of -291 on sale
2025-07-11 SELL -892 35.840 36.080 36.056 USD -32,162 34.99 Loss of -954 on sale
2025-07-10 BUY 1,338 36.120 36.560 36.516 USD 48,858 34.94
2025-07-07 SELL -888 35.590 36.420 36.337 USD -32,267 34.86 Loss of -1,315 on sale
2025-07-03 SELL -222 36.370 36.430 36.424 USD -8,086 34.72 Loss of -379 on sale
2025-06-30 SELL -888 36.030 36.220 36.201 USD -32,146 34.58 Loss of -1,440 on sale
2025-06-27 BUY 1,776 35.870 35.931 35.925 USD 63,803 34.51
2025-06-24 SELL -663 36.140 36.320 36.302 USD -24,068 34.27 Loss of -1,344 on sale
2025-06-23 SELL -221 35.400 35.455 35.450 USD -7,834 34.20 Loss of -276 on sale
2025-06-20 SELL -663 34.860 34.890 34.887 USD -23,130 34.15 Loss of -487 on sale
2025-06-18 SELL -816 34.910 34.990 34.982 USD -28,545 34.03 Loss of -780 on sale
2025-06-17 BUY 1,230 34.560 35.140 35.082 USD 43,151 33.98
2025-06-13 BUY 410 34.840 35.380 35.326 USD 14,484 33.76
2025-06-12 SELL -2,030 35.270 35.370 35.360 USD -71,781 33.57 Loss of -3,639 on sale
2025-06-11 BUY 410 34.050 34.180 34.167 USD 14,008 33.50
2025-06-05 SELL -203 33.750 33.770 33.768 USD -6,855 33.33 Loss of -89 on sale
2025-06-04 BUY 204 33.440 33.715 33.688 USD 6,872 33.27
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-01	SELL	-27	40.500	39.600	39.690	USD -1,072	36.54 Loss of -85 on sale
2025-11-24	BUY	1,873	39.830	37.310	37.562	USD 70,354	36.35
2025-11-18	SELL	-276			39.460*		36.23 Profit of 10,001 on sale
2025-11-10	SELL	-538	39.399	38.510	38.599	USD -20,766	36.00 Loss of -1,396 on sale
2025-11-06	SELL	-269	41.240	40.020	40.142	USD -10,798	35.91 Loss of -1,140 on sale
2025-11-03	BUY	540	37.715	37.130	37.189	USD 20,082	35.80
2025-10-24	SELL	-269	37.260	37.395	37.382	USD -10,056	35.69 Loss of -456 on sale
2025-10-23	BUY	538	36.850	37.160	37.129	USD 19,975	35.67
2025-10-22	BUY	269	36.840	37.690	37.605	USD 10,116	35.65
2025-10-21	SELL	-269	37.480	37.520	37.516	USD -10,092	35.62 Loss of -510 on sale
2025-10-20	BUY	269	36.630	36.920	36.891	USD 9,924	35.60
2025-10-14	SELL	-269	36.000	36.130	36.117	USD -9,715	35.55 Loss of -152 on sale
2025-10-13	BUY	807	35.440	35.975	35.921	USD 28,989	35.55
2025-10-01	BUY	804	36.320	36.455	36.442	USD 29,299	35.50
2025-09-30	BUY	268	35.280	35.540	35.514	USD 9,518	35.50
2025-09-11	SELL	-267	36.700	36.940	36.916	USD -9,857	35.50 Loss of -379 on sale
2025-07-31	BUY	223	36.800	37.550	37.475	USD 8,357	35.38
2025-07-30	SELL	-223	37.120	37.500	37.462	USD -8,354	35.34 Loss of -473 on sale
2025-07-25	SELL	-223	36.670	36.710	36.706	USD -8,185	35.20 Loss of -337 on sale
2025-07-24	BUY	446	36.590	36.660	36.653	USD 16,347	35.16
2025-07-14	SELL	-223	36.240	36.330	36.321	USD -8,100	35.02 Loss of -291 on sale
2025-07-11	SELL	-892	35.840	36.080	36.056	USD -32,162	34.99 Loss of -954 on sale
2025-07-10	BUY	1,338	36.120	36.560	36.516	USD 48,858	34.94
2025-07-07	SELL	-888	35.590	36.420	36.337	USD -32,267	34.86 Loss of -1,315 on sale
2025-07-03	SELL	-222	36.370	36.430	36.424	USD -8,086	34.72 Loss of -379 on sale
2025-06-30	SELL	-888	36.030	36.220	36.201	USD -32,146	34.58 Loss of -1,440 on sale
2025-06-27	BUY	1,776	35.870	35.931	35.925	USD 63,803	34.51
2025-06-24	SELL	-663	36.140	36.320	36.302	USD -24,068	34.27 Loss of -1,344 on sale
2025-06-23	SELL	-221	35.400	35.455	35.450	USD -7,834	34.20 Loss of -276 on sale
2025-06-20	SELL	-663	34.860	34.890	34.887	USD -23,130	34.15 Loss of -487 on sale
2025-06-18	SELL	-816	34.910	34.990	34.982	USD -28,545	34.03 Loss of -780 on sale
2025-06-17	BUY	1,230	34.560	35.140	35.082	USD 43,151	33.98
2025-06-13	BUY	410	34.840	35.380	35.326	USD 14,484	33.76
2025-06-12	SELL	-2,030	35.270	35.370	35.360	USD -71,781	33.57 Loss of -3,639 on sale
2025-06-11	BUY	410	34.050	34.180	34.167	USD 14,008	33.50
2025-06-05	SELL	-203	33.750	33.770	33.768	USD -6,855	33.33 Loss of -89 on sale
2025-06-04	BUY	204	33.440	33.715	33.688	USD 6,872	33.27

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of RPRX

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	877,435	0	1,269,348	69.1%
2025-09-18	854,156	255	1,225,709	69.7%
2025-09-17	890,428	0	1,130,889	78.7%
2025-09-16	849,691	0	1,371,042	62.0%
2025-09-15	1,310,051	875	1,800,476	72.8%
2025-09-12	1,066,120	800	1,339,292	79.6%
2025-09-11	1,220,120	283	1,532,656	79.6%
2025-09-10	1,195,119	790	1,440,333	83.0%
2025-09-09	1,259,853	924	1,521,804	82.8%
2025-09-08	1,967,280	1,094	3,312,547	59.4%
2025-09-05	2,792,926	0	4,789,487	58.3%
2025-09-04	649,497	0	1,396,642	46.5%
2025-09-03	741,511	0	3,964,244	18.7%
2025-09-02	1,164,461	621	1,836,122	63.4%
2025-08-29	568,848	644	1,099,441	51.7%
2025-08-28	343,443	1,229	665,672	51.6%
2025-08-27	718,529	15	1,134,797	63.3%
2025-08-26	376,806	3,158	782,116	48.2%
2025-08-25	523,360	0	1,666,116	31.4%
2025-08-22	416,975	1,403	983,556	42.4%
2025-08-21	515,906	1	789,605	65.3%
2025-08-20	668,934	557	1,359,619	49.2%
2025-08-19	282,363	1,211	801,139	35.2%
2025-08-18	470,777	713	735,143	64.0%
2025-08-15	370,886	0	849,955	43.6%
2025-08-14	437,271	0	1,270,825	34.4%
2025-08-13	450,930	0	2,187,219	20.6%
2025-08-12	378,708	321	1,366,736	27.7%
2025-08-11	566,603	322	1,321,771	42.9%
2025-08-08	732,304	1,141	1,058,552	69.2%
2025-08-07	637,779	141	1,478,119	43.1%
2025-08-06	968,026	95	1,335,306	72.5%
2025-08-05	817,147	97	1,153,956	70.8%
2025-08-04	562,562	677	830,964	67.7%
2025-08-01	356,771	847	641,246	55.6%
2025-07-31	550,713	210	657,912	83.7%
2025-07-30	529,655	432	816,351	64.9%
2025-07-29	600,859	25	752,372	79.9%
2025-07-28	682,728	1,073	824,975	82.8%
2025-07-25	351,993	50	514,201	68.5%
2025-07-24	396,410	57	557,229	71.1%
2025-07-23	289,217	2,996	787,220	36.7%
2025-07-22	460,421	0	666,171	69.1%
2025-07-21	489,845	1,682	693,054	70.7%
2025-07-18	355,376	0	587,434	60.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Edge MSCI USA Momentum Factor UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	IUMD(USD) LSE
ETF Ticker	IUMD.L(GBP) LSE